EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹5.00 Cr | ₹4.91 Cr | ₹5.24 Cr | ₹5.55 Cr | ₹5.45 Cr |
What is the latest Contingent Liabilities ratio of EVEREST ORGANICS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹5.00 Cr |
Mar2023 | ₹4.91 Cr |
Mar2022 | ₹5.24 Cr |
Mar2021 | ₹5.55 Cr |
Mar2020 | ₹5.45 Cr |
How is Contingent Liabilities of EVEREST ORGANICS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹5.00 Cr | 1.83 | |
Mar2023 | ₹4.91 Cr | -6.35 | |
Mar2022 | ₹5.24 Cr | -5.50 | |
Mar2021 | ₹5.55 Cr | 1.72 | |
Mar2020 | ₹5.45 Cr | - |
Compare Contingent Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹310.9 Cr | -2% | -5.7% | 101.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -2% |
-5.7% |
101.8% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses